One of the most destructive products on the market might perhaps be one of the most unlikely. Baby powder, made with talc, has seen a mounting number of lawsuits in the past two years after a potential link to ovarian cancer was exposed.
J&J to Pay Nearly $8 Million to Settle Risperdal Case
Johnson & Johnson recently agreed to pay almost $8 million in a Risperdal settlement.
Talcum Powder and Ovarian Cancer: A Historical Timeline
Since the initial lawsuit in 2013, hundreds have been filed against pharmaceutical and cosmetic manufacturer Johnson & Johnson for the potential risk associated with baby powder.
The Risperdal Side Effect Caused By Dopamine
Manufactured by Janssen, a subsidiary of Johnson & Johnson, Risperdal is an antipsychotic drug originally formulated to treat schizophrenia.
Talcum Powder Ovarian Cancer Risk: A 20 to 30 Percent Increase
Johnson & Johnson’s baby powder product has been under speculation for some time due its potential carcinogenic qualities, but a recent study suggests that the risks associated with using the powder are even higher than we’d previously imagined.
Blood Thinners Turned Bad: The Drugs with No Antidote
Two drugs used to treat serious blood clots and their associated risk have been met with numerous lawsuits and mass torts as a result of undisclosed internal bleeding risks.
Zofran and Risperdal’s Off-Label Use
Many drugs are thoroughly tested by both pharmaceutical companies, helping ensure their safety during patient use.
Johnson and Johnson Lawsuits Stack Up for Numerous Products
Many drugs and medical devices are currently taking heat for unexpected side effects and complications, but one manufacturer is at the forefront of the conversation: Johnson & Johnson.
Risperdal Manufacturers Docked Again For Failure-to-Warn
A trial in the Philadelphia Court of Common Pleas reached another verdict on a case concerning Johnson & Johnson’s drug Risperdal on Friday, March 20, ruling that while the company failed to adequately warn about a major side effect, it would not award damages to plaintiff William Cirba.
Johnson & Johnson to Pay $2.5 Million in Risperdal Damages
Johnson and Johnson has to pay $2.5 million in damages to the family of a boy who developed size 46 DD breasts from taking the drug Risperdal.